PubHawk
March 2017 PMID 28162779

Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills.

Robert F Casper

Download social card

Mentions

24
Peak: 1 in Jun 2023
across 4 sources since Jun 2023

Extended reach

9,842
potential audience

Total likes

199

Video views

9,021

Mentions per month

Jun 2023 – Sep 2024

Where it's discussed

  • News14 articles
  • Facebook6 posts
  • X / Twitter2 posts
  • YouTube2 videos

AI synopsis

What people are saying

The discussions reflect a cautious tone, with remarks like questioning the long-term effects of OCPs and the potential need for alternative treatments, exemplified by phrases such as 'adverse effect' and 'potential worsening,' which highlight concern and curiosity about the article's implications, although the overall engagement remains moderate.

AgreementModerate agreement

The majority of discussions, such as the comment about OCPs possibly worsening endometriosis, suggest some skepticism about traditional treatments, indicating a partial agreement with the idea of exploring better options.

InterestModerate interest

Both comments show a moderate level of interest, with some engaging in sharing their opinions but limited detailed discussion or debate.

EngagementNeutral engagement

The discussions are relatively surface-level, with brief statements rather than in-depth analysis or extensive exchanges.

ImpactNeutral impact

Given the limited reactions and passive tone, these discussions seem to have low overall impact on clinical practice or widespread awareness.

Abstract in brief

  • Progestin-only pills may be more effective than combined estrogen-progestin contraceptive pills for treating endometriosis-related pain, as evidence suggests they can better reduce pelvic pain and the size of endometrial lesions.
  • Traditional combined estrogen-progestin pills have been used for decades without strong clinical proof of their efficacy; their initial pain relief may only target primary dysmenorrhea rather than endometriosis itself, and long-term use could potentially worsen disease progression.
  • There is randomized controlled trial data supporting the use of certain progestin-only medications like norethindrone acetate and dienogest, which are approved for endometriosis treatment and may serve as a better first-line option compared to OCPs.
Read the full abstract

Top posts

Most liked on X and Bluesky
eye&beam ♂ Gender exterminationist
@eyebeam · X

@speakoutsister @LovelyAlice_May @TTExulansic “Initial relief provided by OCPs is likely a result of improvement in primary dysmenorrhea. Biologic data and limited clinical evidence support a potential adverse effect of long-term use of OCPs on the progression of endometriosis.” https://t.co/WDgaDncgOs

Oct 20, 2023 · 463 followers View post →
Hater Juliet
@NeonExpressClog · X

@elonmusk @jordanbpeterson ! https://t.co/dGocfuurbf

Jun 15, 2023 · 359 followers View post →

All mentions

eye&beam ♂ Gender exterminationist
@eyebeam · X

@speakoutsister @LovelyAlice_May @TTExulansic “Initial relief provided by OCPs is likely a result of improvement in primary dysmenorrhea. Biologic data and limited clinical evidence support a potential adverse effect of long-term use of OCPs on the progression of endometriosis.” https://t.co/WDgaDncgOs

Oct 20, 2023 · 463 followers View post →
Hater Juliet
@NeonExpressClog · X

@elonmusk @jordanbpeterson ! https://t.co/dGocfuurbf

Jun 15, 2023 · 359 followers View post →